OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The delta opioid receptor: an evolving target for the treatment of brain disorders
Amynah Pradhan, Katia Befort, Chihiro Nozaki, et al.
Trends in Pharmacological Sciences (2011) Vol. 32, Iss. 10, pp. 581-590
Open Access | Times Cited: 282

Showing 1-25 of 282 citing articles:

Structure of the δ-opioid receptor bound to naltrindole
Sébastien Granier, Aashish Manglik, Andrew C. Kruse, et al.
Nature (2012) Vol. 485, Iss. 7398, pp. 400-404
Open Access | Times Cited: 639

The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
S P H Alexander, Helen E. Benson, Elena Faccenda, et al.
British Journal of Pharmacology (2013) Vol. 170, Iss. 8, pp. 1459-1581
Open Access | Times Cited: 552

Opioid receptors: distinct roles in mood disorders
Pierre‐Eric Lutz, Brigitte L. Kieffer
Trends in Neurosciences (2012) Vol. 36, Iss. 3, pp. 195-206
Open Access | Times Cited: 471

Opioid receptors: drivers to addiction?
Emmanuel Darcq, Brigitte L. Kieffer
Nature reviews. Neuroscience (2018) Vol. 19, Iss. 8, pp. 499-514
Closed Access | Times Cited: 304

A mu–delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks
Eric Erbs, Lauren Faget, Grégory Scherrer, et al.
Brain Structure and Function (2014) Vol. 220, Iss. 2, pp. 677-702
Open Access | Times Cited: 259

Biased Receptor Signaling in Drug Discovery
Terry Kenakin
Pharmacological Reviews (2019) Vol. 71, Iss. 2, pp. 267-315
Open Access | Times Cited: 247

Intracranial Self-Stimulation to Evaluate Abuse Potential of Drugs
S. Stevens Negus, Laurence L. Miller
Pharmacological Reviews (2014) Vol. 66, Iss. 3, pp. 869-917
Open Access | Times Cited: 211

The Kappa Opioid Receptor: From Addiction to Depression, and Back
Laurence Lalanne, Gülebru Ayrancı, Brigitte L. Kieffer, et al.
Frontiers in Psychiatry (2014) Vol. 5
Open Access | Times Cited: 206

β−Arrestins: Structure, Function, Physiology, and Pharmacological Perspectives
Jürgen Wess, Antwi‐Boasiako Oteng, Osvaldo Rivera‐Gonzalez, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 854-884
Open Access | Times Cited: 54

The G Protein–Biased κ-Opioid Receptor Agonist RB-64 Is Analgesic with a Unique Spectrum of Activities In Vivo
Kate L. White, J. Elliott Robinson, Hu Zhu, et al.
Journal of Pharmacology and Experimental Therapeutics (2014) Vol. 352, Iss. 1, pp. 98-109
Open Access | Times Cited: 186

Delta opioid receptors in brain function and diseases
Paul Chu Sin Chung, Brigitte L. Kieffer
Pharmacology & Therapeutics (2013) Vol. 140, Iss. 1, pp. 112-120
Open Access | Times Cited: 142

Ligand‐directed signalling within the opioid receptor family
Amynah Pradhan, Monique L. Smith, Brigitte L. Kieffer, et al.
British Journal of Pharmacology (2012) Vol. 167, Iss. 5, pp. 960-969
Open Access | Times Cited: 142

Historical Review: Opiate Addiction and Opioid Receptors
Shao-Cheng Wang
Cell Transplantation (2018) Vol. 28, Iss. 3, pp. 233-238
Open Access | Times Cited: 140

15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse
Pauline Charbogne, Brigitte L. Kieffer, Katia Befort
Neuropharmacology (2013) Vol. 76, pp. 204-217
Open Access | Times Cited: 139

Functional Selectivity in CB2 Cannabinoid Receptor Signaling and Regulation: Implications for the Therapeutic Potential of CB2 Ligands
Brady K. Atwood, James Wager‐Miller, Christopher B. Haskins, et al.
Molecular Pharmacology (2011) Vol. 81, Iss. 2, pp. 250-263
Open Access | Times Cited: 137

Endogenous opioid systems
Eduardo E. Benarroch
Neurology (2012) Vol. 79, Iss. 8, pp. 807-814
Closed Access | Times Cited: 129

The Efficacy of Buprenorphine in Major Depression, Treatment-Resistant Depression and Suicidal Behavior: A Systematic Review
Gianluca Serafini, Giulia Adavastro, Giovanna Canepa, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 8, pp. 2410-2410
Open Access | Times Cited: 127

The multiple facets of opioid receptor function: implications for addiction
Pierre‐Eric Lutz, Brigitte L. Kieffer
Current Opinion in Neurobiology (2013) Vol. 23, Iss. 4, pp. 473-479
Open Access | Times Cited: 119

Nicotine Gateway Effects on Adolescent Substance Use
Michelle Ren, Shahrdad Lotfipour
Western Journal of Emergency Medicine (2019) Vol. 20, Iss. 5, pp. 696-709
Open Access | Times Cited: 118

Molecular Pharmacology ofδ-Opioid Receptors
Louis Gendron, Catherine M. Cahill, Mark von Zastrow, et al.
Pharmacological Reviews (2016) Vol. 68, Iss. 3, pp. 631-700
Open Access | Times Cited: 108

Biased Opioid Ligands
Abdelfattah Faouzi, Balázs R. Varga, Susruta Majumdar
Molecules (2020) Vol. 25, Iss. 18, pp. 4257-4257
Open Access | Times Cited: 105

Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists
Tobias Claff, Jing Yu, Véronique Blais, et al.
Science Advances (2019) Vol. 5, Iss. 11
Open Access | Times Cited: 102

Pharmacological Chaperones: Design and Development of New Therapeutic Strategies for the Treatment of Conformational Diseases
Marino Convertino, Jhuma Das, Nikolay V. Dokholyan
ACS Chemical Biology (2016) Vol. 11, Iss. 6, pp. 1471-1489
Closed Access | Times Cited: 99

Mu-Opioid receptor biased ligands: A safer and painless discovery of analgesics?
Abraham Madariaga‐Mazón, Andrés F. Marmolejo-Valencia, Yangmei Li, et al.
Drug Discovery Today (2017) Vol. 22, Iss. 11, pp. 1719-1729
Open Access | Times Cited: 98

Page 1 - Next Page

Scroll to top